Tarani Kanta Barman is a biomedical scientist with more than 15 years of research experience in different areas of drug discovery and basic Immunology including infection, inflammation, oncology, diagnostic and vaccine research, and management of laboratory animal facility. His basic training is in bacterial and viral immunity. He has extensive hand on experience of working on animal model of infection, immunology, drug discovery, vaccine, and pre-clinical safety studies. Handled pharmacological studies of several projects and trained many junior scientists/animal facility technicians working on discovery pharmacology. He has expertise in pre-clinical discovery research for infectious diseases from hit to lead optimization, IND-enabling studies, and for regulatory submission. He directed and conducted IND/NDA studies for regulatory submission to US FDA. Tarani has advance level of expertise in anti-infective PK-PD for small molecules and therapeutic antibodies in animal model. He was involved in the design and execution of GLP compliant new animal facility and has complete knowledge of working and management of BSL-3 facility. He has published more than 50 papers in national and international journals and a reviewer for several international journals. Has good communication and leadership skills as well as a good team player. His qualifications are BVSc&AH (veterinary Medicine), MVSc (Microbiology & Immunology), PhD (Nanotechnology & novel drug delivery for respiratory tract)